Refresh

RELISH PHARMACEUTICALS LTD. - Outcome of Board Meeting (EGM on March 28, 2014)


01 Mar 2014
Relish Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 28, 2014, inter alia, has transacted the following businesses:<br/><br/>1. Approval for Issue of 5,00,000 Shares on Preferential basis pursuant to approval of Scheme of amalgamation per Clause No. 9.1 of the approved scheme of arrangement for revival of Relish Pharmaceuticals Limited and Amalgamation of proper Dealcomm Private Limited (Transferor Company) with Relish Pharmaceuticals Limited (Transferee Company) and <br/>Re-organization of Share Capital of Relish Pharmaceuticals Limited (Transferee Company), subject to approval of the office of stock exchange and shareholders;<br/><br/>2. Issuance of notice to the Members of the Company for convening Extra ordinary General Meeting to be held on March 28, 2014 at 11.00 a.m. at 1-2 Moon Light 3rd Floor, Opp. Gurukul Drive-ln-Road, Memnagar, Ahmedabad - 380052.

Source: BSE India

View all announcements for RELISH PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com